InfuSystem Holdings, Inc. (INFU)
| Market Cap | 263.89M |
| Revenue (ttm) | 99.13M |
| Net Income (ttm) | 15.09M |
| Shares Out | 20.57M |
| EPS (ttm) | 0.70 |
| PE Ratio | 18.53 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 75,397 |
| Open | 12.74 |
| Previous Close | 12.74 |
| Day's Range | 12.70 - 13.15 |
| 52-Week Range | 11.65 - 23.26 |
| Beta | 0.88 |
| Analysts | Strong Buy |
| Price Target | 28.00 (+117.4%) |
| Est. Earnings Date | Nov 11, 2021 |
About INFU
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates through two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment (DME) Services. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. T...
Financial Performance
In 2020, INFU's revenue was $97.39 million, an increase of 20.06% compared to the previous year's $81.12 million. Earnings were $17.33 million, an increase of 1,173.48%.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for INFU stock is "Strong Buy." The 12-month stock price forecast is 28.00, which is an increase of 117.39% from the latest price.
News
InfuSystem to Participate in Lake Street's 5th Annual Best Ideas Growth (BIG5) Conference September 14, 2021
Rochester Hills, Michigan, Sept. 08, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitati...
InfuSystems Holdings, Inc. (INFU) Misses Q2 Earnings and Revenue Estimates
InfuSystems Holdings, Inc. (INFU) delivered earnings and revenue surprises of -63.64% and -9.70%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
InfuSystem Reports Second Quarter 2021 Financial Results
Launched Fourth ITS Therapy - Lymphedema Announced $20 million Stock Repurchase Program Updates Guidance for 2021
Analysts Estimate InfuSystems Holdings, Inc. (INFU) to Report a Decline in Earnings: What to Look Out for
InfuSystems Holdings, Inc. (INFU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
InfuSystem to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021
Investor Conference Call to be held 9:00 a.m. Eastern Time Investor Conference Call to be held 9:00 a.m. Eastern Time
Strength Seen in InfuSystems Holdings, Inc. (INFU): Can Its 14.2% Jump Turn into More Strength?
InfuSystems Holdings, Inc. (INFU) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further stre...
InfuSystem Announces $20 Million Stock Repurchase Program
ROCHESTER HILLS, Michigan, June 30, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitatin...
InfuSystem Enters Lymphedema Therapy Market
Providing pneumatic compression devices for last-mile patient care Providing pneumatic compression devices for last-mile patient care
InfuSystem to Participate at Craig-Hallum 18th Annual Institutional Investor Conference June 2, 2021
ROCHESTER HILLS, Michigan, May 27, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company”), a leading national health care service provider, facilitatin...
InfuSystem Reports First Quarter 2021 Financial Results
Net Revenues: $24.5 million, a 14% increase Net Income: $0.7 million, a $1.1 million increase, Adjusted EBITDA: $6.2 million, a 51% increase, and Adjusted EBITDA margin of 25.2%, a 6.3% increase Com...
InfuSystem to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021
Investor Conference Call to be held 9:00 a.m. Eastern Time Investor Conference Call to be held 9:00 a.m. Eastern Time
InfuSystem Acquires OB Healthcare Corporation, Expanding DME Services Platform in Acute Care
ROCHESTER HILLS, Michigan, April 21, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, facilitat...
InfuSystem to Present at Sidoti's Spring 2021 Virtual Conference March 25, 2021
Investor Presentation to be held 9:15 a.m. Eastern Time Investor Presentation to be held 9:15 a.m. Eastern Time
InfuSystem Reports Fourth Quarter and Full Year 2020 Financial Results
Full Year 2020 vs. Full Year 2019: Net Revenues: $97.4 million, a 20% increase Net Income: $17.3 million, a 15.9 million increase, Adjusted EBITDA: $26.2 million, a 44% increase, and Adjusted EBITDA mar...
InfuSystem to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, March 17, 2021
Investor Conference Call to be held 9:00 a.m. Eastern Time Investor Conference Call to be held 9:00 a.m. Eastern Time
InfuSystem Announces Appointment of Carrie Lachance as President
ROCHESTER HILLS, Michigan, March 02, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, facilitati...
InfuSystem Announces New $75 Million Revolving Credit Facility
RODCHESTER HILLS, Michigan, Feb. 11, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, facilitati...
InfuSystem Acquires Biomedical Services Company to Expand DME Services Platform
Rochester Hills, Michigan, Feb. 03, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, facilitati...
A Trio of Small Caps for the Growth-Focused Investor
Growth-focused investors may be interested in the following small-cap stocks, as they represent companies whose trailing 12-month earnings per share improved significantly on a year-over-year basis.
InfuSystem: Strength In Core Businesses Hedges Against COVID-19 Headwinds
InfuSystem is uniquely positioned to benefit from any resurgence in COVID-19, and ex-COVID has strength in the core business model. Shareholders have enjoyed ~120% upside YTD, and shares have the legs t...
InfuSystem Holdings, Inc. Issues Full Year 2021 Guidance
Revenues of $107 million - $110 million; Adjusted EBITDA of $29 million - $30 million; Operating Cash Flow of $21 million - $23 million; Revenues of $107 million - $110 million; Adjusted EBITDA of $29 m...
InfuSystem to Present at 13th Annual LD Micro Main Event Tuesday, December 15, 2020
Rochester Hills, Michigan, Dec. 14, 2020 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, facilitatin...
InfuSystem to Announce Full Year 2021 Guidance on Tuesday, December 15, 2020
Conference Call to be held 9:00 a.m. Eastern Time Conference Call to be held 9:00 a.m. Eastern Time
InfuSystem to Present at Craig-Hallum Capital Group and Sidoti & Company Investment Conferences
ROCHESTER HILLS, Michigan, Nov. 16, 2020 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company”), a leading national health care service provider, facilitati...